APA (7th ed.) Citation

JD, K., IF, M., JBL, L., TC, S., & Z, D. (2026). Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. Clinical and translational science, 19(2), e70476. https://doi.org/10.1111/cts.70476

Chicago Style (17th ed.) Citation

JD, Kim, Metzger IF, Lu JBL, Skaar TC, and Desta Z. "Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants." Clinical and Translational Science 19, no. 2 (2026): e70476. https://doi.org/10.1111/cts.70476.

MLA (9th ed.) Citation

JD, Kim, et al. "Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants." Clinical and Translational Science, vol. 19, no. 2, 2026, p. e70476, https://doi.org/10.1111/cts.70476.